JP3156933B2 - 縮合チオフェン化合物およびその医薬用途 - Google Patents
縮合チオフェン化合物およびその医薬用途Info
- Publication number
- JP3156933B2 JP3156933B2 JP51595799A JP51595799A JP3156933B2 JP 3156933 B2 JP3156933 B2 JP 3156933B2 JP 51595799 A JP51595799 A JP 51595799A JP 51595799 A JP51595799 A JP 51595799A JP 3156933 B2 JP3156933 B2 JP 3156933B2
- Authority
- JP
- Japan
- Prior art keywords
- benzothieno
- benzodiazepine
- methyl
- fluoro
- methylpiperazin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003577 thiophenes Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 248
- -1 thiophene compound Chemical class 0.000 claims abstract description 236
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims abstract description 61
- 229930192474 thiophene Natural products 0.000 claims abstract description 44
- 150000003839 salts Chemical class 0.000 claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 17
- 150000004677 hydrates Chemical class 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 101
- 229910052739 hydrogen Inorganic materials 0.000 claims description 101
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 86
- 239000001257 hydrogen Substances 0.000 claims description 76
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 59
- 125000001424 substituent group Chemical group 0.000 claims description 56
- 125000003545 alkoxy group Chemical group 0.000 claims description 50
- 229910052736 halogen Inorganic materials 0.000 claims description 49
- 150000002367 halogens Chemical class 0.000 claims description 49
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 32
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 27
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 27
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 27
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 25
- ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical compound N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 claims description 22
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 21
- 125000003118 aryl group Chemical group 0.000 claims description 21
- 125000002252 acyl group Chemical group 0.000 claims description 19
- 150000001350 alkyl halides Chemical class 0.000 claims description 19
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims description 19
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 19
- 125000001072 heteroaryl group Chemical group 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 16
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 13
- LDBHGFASMHVSDJ-UHFFFAOYSA-N 12-(4-ethylpiperazin-1-yl)-8-fluoro-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(CC)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=CC=C1S2 LDBHGFASMHVSDJ-UHFFFAOYSA-N 0.000 claims description 11
- FCEHBMOGCRZNNI-UHFFFAOYSA-N thianaphthalene Natural products C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims description 11
- 230000000561 anti-psychotic effect Effects 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 125000004442 acylamino group Chemical group 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 8
- OMXPIBMAAAQVAY-UHFFFAOYSA-N 3-methoxy-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound S1C2=CC(OC)=CC=C2C2=C1NC1=CC=CC=C1N=C2N1CCN(C)CC1 OMXPIBMAAAQVAY-UHFFFAOYSA-N 0.000 claims description 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 7
- IEIVTDQRSPHBLU-UHFFFAOYSA-N 2-methyl-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=CC(C)=CC=C1S2 IEIVTDQRSPHBLU-UHFFFAOYSA-N 0.000 claims description 6
- AUCLWJLFODRMBQ-UHFFFAOYSA-N 8-fluoro-3-methoxy-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound S1C2=CC(OC)=CC=C2C2=C1NC1=CC(F)=CC=C1N=C2N1CCN(C)CC1 AUCLWJLFODRMBQ-UHFFFAOYSA-N 0.000 claims description 6
- KIDXKPHBWBBXHV-UHFFFAOYSA-N 11h-[1]benzothiolo[2,3-b][1,5]benzothiazepin-12-one Chemical compound O=C1NC2=CC=CC=C2SC2=C1C1=CC=CC=C1S2 KIDXKPHBWBBXHV-UHFFFAOYSA-N 0.000 claims description 5
- ORMHHWRIFGOWEO-UHFFFAOYSA-N 3-chloro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=CC=C(Cl)C=C1S2 ORMHHWRIFGOWEO-UHFFFAOYSA-N 0.000 claims description 5
- SBWPGPZIESAXOL-UHFFFAOYSA-N 3-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=CC=C(F)C=C1S2 SBWPGPZIESAXOL-UHFFFAOYSA-N 0.000 claims description 5
- CQSDGAYUGYEAPC-UHFFFAOYSA-N 3-methyl-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=CC=C(C)C=C1S2 CQSDGAYUGYEAPC-UHFFFAOYSA-N 0.000 claims description 5
- UEBZSIALEXRBAH-UHFFFAOYSA-N 4-methyl-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=CC=CC(C)=C1S2 UEBZSIALEXRBAH-UHFFFAOYSA-N 0.000 claims description 5
- NXUQLWOTAQSNFN-UHFFFAOYSA-N 8,10-difluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=C(F)C=C(F)C=C2NC2=C1C1=CC=CC=C1S2 NXUQLWOTAQSNFN-UHFFFAOYSA-N 0.000 claims description 5
- DFGBJIQJTUWFCP-UHFFFAOYSA-N 8,9-difluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC(F)=C(F)C=C2NC2=C1C1=CC=CC=C1S2 DFGBJIQJTUWFCP-UHFFFAOYSA-N 0.000 claims description 5
- BJWOMTDXLMCLPP-UHFFFAOYSA-N 8-chloro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(Cl)C=C2NC2=C1C1=CC=CC=C1S2 BJWOMTDXLMCLPP-UHFFFAOYSA-N 0.000 claims description 5
- JPMWEGWVYPOXBE-UHFFFAOYSA-N 9-methyl-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC(C)=CC=C2NC2=C1C1=CC=CC=C1S2 JPMWEGWVYPOXBE-UHFFFAOYSA-N 0.000 claims description 5
- ZUSLUAJQONYLNH-UHFFFAOYSA-N 1-methyl-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=C(C)C=CC=C1S2 ZUSLUAJQONYLNH-UHFFFAOYSA-N 0.000 claims description 4
- DTLCBJQHOOLOPZ-UHFFFAOYSA-N 11h-[1]benzothiolo[2,3-b][1,5]benzoxazepin-12-one Chemical compound O=C1NC2=CC=CC=C2OC2=C1C1=CC=CC=C1S2 DTLCBJQHOOLOPZ-UHFFFAOYSA-N 0.000 claims description 4
- KPKRDWDGRHMMNX-UHFFFAOYSA-N 3-bromo-8-fluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=C(Br)C=C1S2 KPKRDWDGRHMMNX-UHFFFAOYSA-N 0.000 claims description 4
- AWKLSXDWEVRTTM-UHFFFAOYSA-N 8,9-dichloro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=C(Cl)C=C2NC2=C1C1=CC=CC=C1S2 AWKLSXDWEVRTTM-UHFFFAOYSA-N 0.000 claims description 4
- UOAJCDRDYHBCRK-UHFFFAOYSA-N 8-fluoro-11h-[1]benzothiolo[2,3-b][1,5]benzoxazepin-12-one Chemical compound O1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 UOAJCDRDYHBCRK-UHFFFAOYSA-N 0.000 claims description 4
- YJFJIYZTSWKSNN-UHFFFAOYSA-N 8-fluoro-2-methyl-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC(C)=CC=C1S2 YJFJIYZTSWKSNN-UHFFFAOYSA-N 0.000 claims description 4
- RVRXXWFHKUVBMP-UHFFFAOYSA-N 8-methyl-11h-[1]benzothiolo[2,3-b][1,5]benzoxazepin-12-one Chemical compound O1C2=CC(C)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 RVRXXWFHKUVBMP-UHFFFAOYSA-N 0.000 claims description 4
- HXVRTRGNQYQYSO-UHFFFAOYSA-N 8-methyl-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(C)C=C2NC2=C1C1=CC=CC=C1S2 HXVRTRGNQYQYSO-UHFFFAOYSA-N 0.000 claims description 4
- KFQBKKGHLATIMC-UHFFFAOYSA-N 9-bromo-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC(Br)=CC=C2NC2=C1C1=CC=CC=C1S2 KFQBKKGHLATIMC-UHFFFAOYSA-N 0.000 claims description 4
- WPCSQYIOOWXWBY-UHFFFAOYSA-N 9-chloro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=C1C1=CC=CC=C1S2 WPCSQYIOOWXWBY-UHFFFAOYSA-N 0.000 claims description 4
- FUBSSALDUXFRCU-UHFFFAOYSA-N 9-methoxy-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound N=1C2=CC(OC)=CC=C2NC=2SC3=CC=CC=C3C=2C=1N1CCN(C)CC1 FUBSSALDUXFRCU-UHFFFAOYSA-N 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- HKQNVPZNLBGFAM-UHFFFAOYSA-N 1-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC=CC=C2NC(=O)C2=C1SC1=C2C(C)=CC=C1 HKQNVPZNLBGFAM-UHFFFAOYSA-N 0.000 claims description 3
- ABOCGKPQHOVHQD-UHFFFAOYSA-N 12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=CC=CC=C1S2 ABOCGKPQHOVHQD-UHFFFAOYSA-N 0.000 claims description 3
- ZHITYNDURKDYFQ-UHFFFAOYSA-N 2-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC=CC=C2NC(=O)C2=C1SC1=CC=C(C)C=C12 ZHITYNDURKDYFQ-UHFFFAOYSA-N 0.000 claims description 3
- QUZBLWZJTVKOMI-UHFFFAOYSA-N 3,8-difluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=C(F)C=C1S2 QUZBLWZJTVKOMI-UHFFFAOYSA-N 0.000 claims description 3
- QYNLBODOBMFYQO-UHFFFAOYSA-N 3,9-dimethyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC(C)=CC=C2NC2=C1C1=CC=C(C)C=C1S2 QYNLBODOBMFYQO-UHFFFAOYSA-N 0.000 claims description 3
- KJDIEBXLYBONQH-UHFFFAOYSA-N 3-bromo-8-fluoro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=CC(Br)=CC=C21 KJDIEBXLYBONQH-UHFFFAOYSA-N 0.000 claims description 3
- WKRGGBLGDBWFQQ-UHFFFAOYSA-N 3-chloro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC=CC=C2NC(=O)C2=C1SC1=CC(Cl)=CC=C12 WKRGGBLGDBWFQQ-UHFFFAOYSA-N 0.000 claims description 3
- LOFBLCUOUXRTAX-UHFFFAOYSA-N 3-fluoro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC=CC=C2NC(=O)C2=C1SC1=CC(F)=CC=C12 LOFBLCUOUXRTAX-UHFFFAOYSA-N 0.000 claims description 3
- UVYBDZKWISGHJL-UHFFFAOYSA-N 3-methoxy-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC=CC=C2NC(=O)C2=C1SC1=CC(OC)=CC=C12 UVYBDZKWISGHJL-UHFFFAOYSA-N 0.000 claims description 3
- HYJDIOSKJXTJIT-UHFFFAOYSA-N 3-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC=CC=C2NC(=O)C2=C1SC1=CC(C)=CC=C12 HYJDIOSKJXTJIT-UHFFFAOYSA-N 0.000 claims description 3
- KRYZIONVVDGLFG-UHFFFAOYSA-N 4-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC=CC=C2NC(=O)C2=C1SC1=C2C=CC=C1C KRYZIONVVDGLFG-UHFFFAOYSA-N 0.000 claims description 3
- VWJVNPOQPKSZPP-UHFFFAOYSA-N 6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC=CC=C2NC2=C1C1=CC=CC=C1S2 VWJVNPOQPKSZPP-UHFFFAOYSA-N 0.000 claims description 3
- WDBOJRYBWDHVAP-UHFFFAOYSA-N 7,8-dichloro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=C(Cl)C(Cl)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 WDBOJRYBWDHVAP-UHFFFAOYSA-N 0.000 claims description 3
- RAVKLCSJXHSLMV-UHFFFAOYSA-N 8,9-dichloro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C=2SC3=CC=CC=C3C=2C(=O)NC2=C1C=C(Cl)C(Cl)=C2 RAVKLCSJXHSLMV-UHFFFAOYSA-N 0.000 claims description 3
- NTBZWOMSYKOGGV-UHFFFAOYSA-N 8,9-difluoro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C=2SC3=CC=CC=C3C=2C(=O)NC2=C1C=C(F)C(F)=C2 NTBZWOMSYKOGGV-UHFFFAOYSA-N 0.000 claims description 3
- JOCOPNUOFDVNPX-UHFFFAOYSA-N 8-bromo-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(Br)C=C2NC2=C1C1=CC=CC=C1S2 JOCOPNUOFDVNPX-UHFFFAOYSA-N 0.000 claims description 3
- BQUUDTPTCGIGQO-UHFFFAOYSA-N 8-bromo-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(Br)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 BQUUDTPTCGIGQO-UHFFFAOYSA-N 0.000 claims description 3
- VRWKDJZKWVFNEK-UHFFFAOYSA-N 8-fluoro-11h-[1]benzothiolo[2,3-b][1,5]benzothiazepin-12-one Chemical compound S1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 VRWKDJZKWVFNEK-UHFFFAOYSA-N 0.000 claims description 3
- OEKJGDHJRXWPMN-UHFFFAOYSA-N 8-fluoro-2-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=CC=C(C)C=C12 OEKJGDHJRXWPMN-UHFFFAOYSA-N 0.000 claims description 3
- ZLHQONMJAKKIGL-UHFFFAOYSA-N 8-fluoro-3-methoxy-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=CC(OC)=CC=C12 ZLHQONMJAKKIGL-UHFFFAOYSA-N 0.000 claims description 3
- XHPDBXYFQJINGB-UHFFFAOYSA-N 8-fluoro-3-methyl-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=C(C)C=C1S2 XHPDBXYFQJINGB-UHFFFAOYSA-N 0.000 claims description 3
- MKXPMUMDZRQTMY-UHFFFAOYSA-N 8-fluoro-3-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=CC(C)=CC=C12 MKXPMUMDZRQTMY-UHFFFAOYSA-N 0.000 claims description 3
- QOANZQUOIRMQAM-UHFFFAOYSA-N 8-fluoro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 QOANZQUOIRMQAM-UHFFFAOYSA-N 0.000 claims description 3
- QFXWONZDACJPHG-UHFFFAOYSA-N 8-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(C)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 QFXWONZDACJPHG-UHFFFAOYSA-N 0.000 claims description 3
- ZDTIOFNPELUOEM-UHFFFAOYSA-N 9-(trifluoromethyl)-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC(C(F)(F)F)=CC=C2NC2=C1C1=CC=CC=C1S2 ZDTIOFNPELUOEM-UHFFFAOYSA-N 0.000 claims description 3
- RXYGFXMWOJTYQA-UHFFFAOYSA-N 9-bromo-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC(Br)=CC=C2NC2=C1C1=CC=CC=C1S2 RXYGFXMWOJTYQA-UHFFFAOYSA-N 0.000 claims description 3
- LJCHCLAIHDGNPT-UHFFFAOYSA-N 9-chloro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC(Cl)=CC=C2NC2=C1C1=CC=CC=C1S2 LJCHCLAIHDGNPT-UHFFFAOYSA-N 0.000 claims description 3
- LNWANSNNAOTXOR-UHFFFAOYSA-N 9-fluoro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC(F)=CC=C2NC2=C1C1=CC=CC=C1S2 LNWANSNNAOTXOR-UHFFFAOYSA-N 0.000 claims description 3
- JXXGLFQRDBGFTE-UHFFFAOYSA-N 9-methoxy-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC(OC)=CC=C2NC2=C1C1=CC=CC=C1S2 JXXGLFQRDBGFTE-UHFFFAOYSA-N 0.000 claims description 3
- YKXJLYGLHCHFJX-UHFFFAOYSA-N 9-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC(C)=CC=C2NC2=C1C1=CC=CC=C1S2 YKXJLYGLHCHFJX-UHFFFAOYSA-N 0.000 claims description 3
- LCECBUJXJNMUOI-UHFFFAOYSA-N 3-fluoro-8-methyl-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(C)=CC=C2NC(=O)C2=C1SC1=CC(F)=CC=C21 LCECBUJXJNMUOI-UHFFFAOYSA-N 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 8
- XBLZLXJESLILKZ-UHFFFAOYSA-N 6-methyl-11h-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound O=C1NC2=CC=CC=C2N(C)C2=C1C1=CC=CC=C1S2 XBLZLXJESLILKZ-UHFFFAOYSA-N 0.000 claims 1
- MJGBPUCBOWMZOR-UHFFFAOYSA-N 8-methyl-11h-[1]benzothiolo[2,3-b][1,5]benzothiazepin-12-one Chemical compound S1C2=CC(C)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 MJGBPUCBOWMZOR-UHFFFAOYSA-N 0.000 claims 1
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 16
- 201000000980 schizophrenia Diseases 0.000 abstract description 13
- 239000000164 antipsychotic agent Substances 0.000 abstract description 8
- 201000010000 Agranulocytosis Diseases 0.000 abstract description 7
- 208000024827 Alzheimer disease Diseases 0.000 abstract description 6
- 229940124597 therapeutic agent Drugs 0.000 abstract description 3
- 208000019430 Motor disease Diseases 0.000 abstract 1
- 208000028683 bipolar I disease Diseases 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 279
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 247
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 225
- 239000002904 solvent Substances 0.000 description 206
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 183
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 180
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 135
- 238000006243 chemical reaction Methods 0.000 description 131
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 126
- 230000015572 biosynthetic process Effects 0.000 description 120
- 238000003786 synthesis reaction Methods 0.000 description 120
- 238000000034 method Methods 0.000 description 113
- 239000002994 raw material Substances 0.000 description 104
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 96
- 239000000243 solution Substances 0.000 description 96
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 89
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 82
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 81
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 81
- 239000000203 mixture Substances 0.000 description 79
- 239000013078 crystal Substances 0.000 description 78
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 76
- 238000005160 1H NMR spectroscopy Methods 0.000 description 75
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 72
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 71
- 238000002844 melting Methods 0.000 description 70
- 230000008018 melting Effects 0.000 description 70
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 68
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 66
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 65
- 238000003756 stirring Methods 0.000 description 60
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 60
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 57
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 57
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 56
- 239000012046 mixed solvent Substances 0.000 description 55
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 54
- 238000010992 reflux Methods 0.000 description 53
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 52
- 238000001914 filtration Methods 0.000 description 51
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 48
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 48
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 46
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 46
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 42
- 229910000027 potassium carbonate Inorganic materials 0.000 description 41
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 40
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 39
- 239000008096 xylene Substances 0.000 description 39
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 38
- 238000010898 silica gel chromatography Methods 0.000 description 38
- 238000010438 heat treatment Methods 0.000 description 37
- 229940015849 thiophene Drugs 0.000 description 37
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 30
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 30
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 30
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 29
- 229910052938 sodium sulfate Inorganic materials 0.000 description 29
- 235000011152 sodium sulphate Nutrition 0.000 description 29
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 28
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 28
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 26
- 125000004432 carbon atom Chemical group C* 0.000 description 26
- 238000001816 cooling Methods 0.000 description 26
- 238000000354 decomposition reaction Methods 0.000 description 24
- 239000011976 maleic acid Substances 0.000 description 24
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 24
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 24
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 23
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 23
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 22
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 22
- 150000002431 hydrogen Chemical class 0.000 description 22
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 20
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 16
- XNASJEQIJMDBQN-UHFFFAOYSA-N ethyl 2-amino-1-benzothiophene-3-carboxylate Chemical compound C1=CC=C2C(C(=O)OCC)=C(N)SC2=C1 XNASJEQIJMDBQN-UHFFFAOYSA-N 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 16
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 15
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 15
- 150000007529 inorganic bases Chemical class 0.000 description 15
- 229910000029 sodium carbonate Inorganic materials 0.000 description 15
- 239000012312 sodium hydride Substances 0.000 description 15
- 229910000104 sodium hydride Inorganic materials 0.000 description 15
- 239000007858 starting material Substances 0.000 description 15
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 13
- DZMYKWBJZZTINV-UHFFFAOYSA-N 2-bromo-5-methylthiophene-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=C(Br)S1 DZMYKWBJZZTINV-UHFFFAOYSA-N 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 13
- 150000007530 organic bases Chemical class 0.000 description 13
- DRBLTQNCQJXSNU-UHFFFAOYSA-N 1-benzothiophene-3-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CSC2=C1 DRBLTQNCQJXSNU-UHFFFAOYSA-N 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 125000005605 benzo group Chemical group 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 12
- 235000019341 magnesium sulphate Nutrition 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- 229910052708 sodium Inorganic materials 0.000 description 12
- 230000002194 synthesizing effect Effects 0.000 description 12
- 238000005406 washing Methods 0.000 description 12
- RMPKIUVDOPQOLS-UHFFFAOYSA-N 8-fluoro-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-12-amine;hydrochloride Chemical compound Cl.NC1=NC2=CC=C(F)C=C2NC2=C1C1=CC=CC=C1S2 RMPKIUVDOPQOLS-UHFFFAOYSA-N 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 11
- 150000003613 toluenes Chemical class 0.000 description 11
- ILMHNKKMKWQVCE-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=CC=C1S2 ILMHNKKMKWQVCE-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- 229920006395 saturated elastomer Polymers 0.000 description 10
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 9
- 229940049706 benzodiazepine Drugs 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- 229960004170 clozapine Drugs 0.000 description 9
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 9
- 239000005457 ice water Substances 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
- RJXOVESYJFXCGI-UHFFFAOYSA-N 2,4-difluoro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1F RJXOVESYJFXCGI-UHFFFAOYSA-N 0.000 description 8
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 8
- HNUUKNDCZZFORM-UHFFFAOYSA-N 2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C)=C2 HNUUKNDCZZFORM-UHFFFAOYSA-N 0.000 description 8
- YKUQKDRGRFCTKB-UHFFFAOYSA-N 6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1=NC2=CC=CC=C2NC2=C1C1=CC=CC=C1S2 YKUQKDRGRFCTKB-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 239000001530 fumaric acid Substances 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 210000000653 nervous system Anatomy 0.000 description 8
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 8
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 8
- 229910003446 platinum oxide Inorganic materials 0.000 description 8
- YNVOMSDITJMNET-UHFFFAOYSA-N thiophene-3-carboxylic acid Chemical compound OC(=O)C=1C=CSC=1 YNVOMSDITJMNET-UHFFFAOYSA-N 0.000 description 8
- GZNAASVAJNXPPW-UHFFFAOYSA-M tin(4+) chloride dihydrate Chemical compound O.O.[Cl-].[Sn+4] GZNAASVAJNXPPW-UHFFFAOYSA-M 0.000 description 8
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Substances O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 8
- DHBXNPKRAUYBTH-UHFFFAOYSA-N 1,1-ethanedithiol Chemical compound CC(S)S DHBXNPKRAUYBTH-UHFFFAOYSA-N 0.000 description 7
- PWKNBLFSJAVFAB-UHFFFAOYSA-N 1-fluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1F PWKNBLFSJAVFAB-UHFFFAOYSA-N 0.000 description 7
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 229930195712 glutamate Natural products 0.000 description 7
- 239000000543 intermediate Substances 0.000 description 7
- 150000007522 mineralic acids Chemical class 0.000 description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 102000015554 Dopamine receptor Human genes 0.000 description 6
- 108050004812 Dopamine receptor Proteins 0.000 description 6
- 206010018687 Granulocytopenia Diseases 0.000 description 6
- 125000004945 acylaminoalkyl group Chemical group 0.000 description 6
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 6
- 125000003342 alkenyl group Chemical group 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 229940005529 antipsychotics Drugs 0.000 description 6
- 229940127236 atypical antipsychotics Drugs 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 150000007942 carboxylates Chemical class 0.000 description 6
- 208000010877 cognitive disease Diseases 0.000 description 6
- WDCDAAMJNUHOIY-UHFFFAOYSA-N ethyl acetate;2-propan-2-yloxypropane Chemical compound CCOC(C)=O.CC(C)OC(C)C WDCDAAMJNUHOIY-UHFFFAOYSA-N 0.000 description 6
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 6
- PFTYJHIGVCPOSJ-UHFFFAOYSA-N 2,3,4,11-tetrahydro-1h-[1]benzothiolo[2,3-b][1,5]benzoxazepin-12-one Chemical compound O=C1NC2=CC=CC=C2OC2=C1C(CCCC1)=C1S2 PFTYJHIGVCPOSJ-UHFFFAOYSA-N 0.000 description 5
- OEVXSHGJJCIEJG-UHFFFAOYSA-N 2,8-dimethyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC(C)=CC=C2NC(=O)C2=C1SC(C)=C2 OEVXSHGJJCIEJG-UHFFFAOYSA-N 0.000 description 5
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- BDINXVWBBJGVFA-UHFFFAOYSA-N 5h-1,2-benzoxazepin-4-one Chemical compound O1N=CC(=O)CC2=CC=CC=C21 BDINXVWBBJGVFA-UHFFFAOYSA-N 0.000 description 5
- VHTDOHQYIYRUTJ-UHFFFAOYSA-N 8-chloro-2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC(Cl)=CC=C2NC(=O)C2=C1SC(C)=C2 VHTDOHQYIYRUTJ-UHFFFAOYSA-N 0.000 description 5
- XMCSIFKEDRSJGE-UHFFFAOYSA-N 8-fluoro-2,3,4,11-tetrahydro-1h-[1]benzothiolo[2,3-b][1,5]benzothiazepin-12-one Chemical compound S1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=C2CCCC1 XMCSIFKEDRSJGE-UHFFFAOYSA-N 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 5
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 5
- 206010029350 Neurotoxicity Diseases 0.000 description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 5
- 206010044221 Toxic encephalopathy Diseases 0.000 description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 231100000228 neurotoxicity Toxicity 0.000 description 5
- 230000007135 neurotoxicity Effects 0.000 description 5
- 229910017604 nitric acid Inorganic materials 0.000 description 5
- 229960005017 olanzapine Drugs 0.000 description 5
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- FRTWYYNWAOILSW-UHFFFAOYSA-N thieno[2,3-b][1,5]benzoxazepine Chemical compound C1=NC2=CC=CC=C2OC2=C1C=CS2 FRTWYYNWAOILSW-UHFFFAOYSA-N 0.000 description 5
- XNMFPRJGFYVVDH-UHFFFAOYSA-N 2,3-dimethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=C1C(C)=C(C)S2 XNMFPRJGFYVVDH-UHFFFAOYSA-N 0.000 description 4
- GHUPTTDFHNSDCC-UHFFFAOYSA-N 2,6-dimethyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC(C)=C2NC(=O)C2=C1SC(C)=C2 GHUPTTDFHNSDCC-UHFFFAOYSA-N 0.000 description 4
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 4
- OXDWVLAFVDRFFT-UHFFFAOYSA-N 2-bromothiophene-3-carboxamide Chemical compound NC(=O)C=1C=CSC=1Br OXDWVLAFVDRFFT-UHFFFAOYSA-N 0.000 description 4
- ZIWSZVGZEHWZDJ-UHFFFAOYSA-N 2-ethyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(CC)=C2 ZIWSZVGZEHWZDJ-UHFFFAOYSA-N 0.000 description 4
- ZFLGNJKZCQYDKN-UHFFFAOYSA-N 8-methyl-2,3,4,11-tetrahydro-1h-[1]benzothiolo[2,3-b][1,5]benzothiazepin-12-one Chemical compound S1C2=CC(C)=CC=C2NC(=O)C2=C1SC1=C2CCCC1 ZFLGNJKZCQYDKN-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000012320 chlorinating reagent Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 229960003638 dopamine Drugs 0.000 description 4
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- ROJNMGYMBLNTPK-UHFFFAOYSA-N 1,2,4-trifluoro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(F)=C(F)C=C1F ROJNMGYMBLNTPK-UHFFFAOYSA-N 0.000 description 3
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 3
- UUORGSXWPOMXJJ-UHFFFAOYSA-N 1-[azido(ethyl)phosphoryl]ethane Chemical compound CCP(=O)(CC)N=[N+]=[N-] UUORGSXWPOMXJJ-UHFFFAOYSA-N 0.000 description 3
- WBXHAYDGMCONLX-UHFFFAOYSA-N 1-benzothiophene-3-carbonitrile Chemical compound C1=CC=C2C(C#N)=CSC2=C1 WBXHAYDGMCONLX-UHFFFAOYSA-N 0.000 description 3
- REZDERXFCZZZLU-UHFFFAOYSA-N 2,3,4,11-tetrahydro-1h-[1]benzothiolo[2,3-b][1,5]benzothiazepin-12-one Chemical compound O=C1NC2=CC=CC=C2SC2=C1C(CCCC1)=C1S2 REZDERXFCZZZLU-UHFFFAOYSA-N 0.000 description 3
- DPACDUNWMZUWTJ-UHFFFAOYSA-N 2,6-dimethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=C(C)C=CC=C2OC2=C1C=C(C)S2 DPACDUNWMZUWTJ-UHFFFAOYSA-N 0.000 description 3
- PSCYLRDKWFNTIO-UHFFFAOYSA-N 2,8-dimethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(C)C=C2OC2=C1C=C(C)S2 PSCYLRDKWFNTIO-UHFFFAOYSA-N 0.000 description 3
- ATFBUDJRLRUFDL-UHFFFAOYSA-N 2,9-dimethyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=C(C)C=CC=C2NC(=O)C2=C1SC(C)=C2 ATFBUDJRLRUFDL-UHFFFAOYSA-N 0.000 description 3
- KUANQABNAAGHGX-UHFFFAOYSA-N 2-acetyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(=O)C)=C2 KUANQABNAAGHGX-UHFFFAOYSA-N 0.000 description 3
- WNXWDETZPAYBPB-UHFFFAOYSA-N 2-amino-1-benzothiophene-3-carbonitrile Chemical compound C1=CC=C2C(C#N)=C(N)SC2=C1 WNXWDETZPAYBPB-UHFFFAOYSA-N 0.000 description 3
- IYHZRXFCOGQQDM-UHFFFAOYSA-N 2-bromo-5-methylthiophene-3-carboxamide Chemical compound CC1=CC(C(N)=O)=C(Br)S1 IYHZRXFCOGQQDM-UHFFFAOYSA-N 0.000 description 3
- NJJYJPMYBSLRGI-UHFFFAOYSA-N 2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=C1C=C(C)S2 NJJYJPMYBSLRGI-UHFFFAOYSA-N 0.000 description 3
- ZDEWSZZMQVGWCA-UHFFFAOYSA-N 2-methylthiophene-3-carboxamide Chemical compound CC=1SC=CC=1C(N)=O ZDEWSZZMQVGWCA-UHFFFAOYSA-N 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
- QWAGYCFSXYAPAE-UHFFFAOYSA-N 3-fluoro-8-methyl-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(C)C=C2NC2=C1C1=CC=C(F)C=C1S2 QWAGYCFSXYAPAE-UHFFFAOYSA-N 0.000 description 3
- LZNUPQPAULVPPX-UHFFFAOYSA-N 5h-1,5-benzoxazepin-4-one Chemical compound O1C=CC(=O)NC2=CC=CC=C21 LZNUPQPAULVPPX-UHFFFAOYSA-N 0.000 description 3
- FELDOVXSZWCZOU-UHFFFAOYSA-N 7,8-dichloro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(Cl)C(Cl)=C2NC2=C1C1=CC=CC=C1S2 FELDOVXSZWCZOU-UHFFFAOYSA-N 0.000 description 3
- AHNHWPMRIUHTRI-UHFFFAOYSA-N 8-chloro-2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(Cl)C=C2OC2=C1C=C(C)S2 AHNHWPMRIUHTRI-UHFFFAOYSA-N 0.000 description 3
- RENQIYCPGVPZMF-UHFFFAOYSA-N 8-fluoro-2,3,4,11-tetrahydro-1h-[1]benzothiolo[2,3-b][1,5]benzoxazepin-12-one Chemical compound O1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=C2CCCC1 RENQIYCPGVPZMF-UHFFFAOYSA-N 0.000 description 3
- WZJZHBDLEUPLSZ-UHFFFAOYSA-N 8-fluoro-2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2OC2=C1C=C(C)S2 WZJZHBDLEUPLSZ-UHFFFAOYSA-N 0.000 description 3
- IJWNZHWQGFOHGA-UHFFFAOYSA-N 8-fluoro-2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC(F)=CC=C2NC(=O)C2=C1SC(C)=C2 IJWNZHWQGFOHGA-UHFFFAOYSA-N 0.000 description 3
- NIWYIVLXQJBRNR-UHFFFAOYSA-N 8-methoxy-2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC(OC)=CC=C2NC(=O)C2=C1SC(C)=C2 NIWYIVLXQJBRNR-UHFFFAOYSA-N 0.000 description 3
- RMVWPJJRQAEXRR-UHFFFAOYSA-N 9-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC(F)=CC=C2NC2=C1C1=CC=CC=C1S2 RMVWPJJRQAEXRR-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000003693 atypical antipsychotic agent Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 3
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 3
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 3
- GNQDTAQXURPNNS-UHFFFAOYSA-N ethyl 2-(2-aminoanilino)-6-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(C)=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1N GNQDTAQXURPNNS-UHFFFAOYSA-N 0.000 description 3
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- MOTRZVVGCFFABN-UHFFFAOYSA-N hexane;2-propan-2-yloxypropane Chemical compound CCCCCC.CC(C)OC(C)C MOTRZVVGCFFABN-UHFFFAOYSA-N 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 3
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- PPOJWDMKBVWXMU-UHFFFAOYSA-N methyl 2-amino-5-methyl-1-benzothiophene-3-carboxylate Chemical compound C1=C(C)C=C2C(C(=O)OC)=C(N)SC2=C1 PPOJWDMKBVWXMU-UHFFFAOYSA-N 0.000 description 3
- XVDBWWRIXBMVJV-UHFFFAOYSA-N n-[bis(dimethylamino)phosphanyl]-n-methylmethanamine Chemical compound CN(C)P(N(C)C)N(C)C XVDBWWRIXBMVJV-UHFFFAOYSA-N 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000009518 sodium iodide Nutrition 0.000 description 3
- 239000012453 solvate Substances 0.000 description 3
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- XNJAYQHWXYJBBD-UHFFFAOYSA-N 1,4-difluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(F)=CC=C1F XNJAYQHWXYJBBD-UHFFFAOYSA-N 0.000 description 2
- FLNQAPQQAZVRDA-UHFFFAOYSA-N 1-(2-(2-Hydroxyethoxy)ethyl)piperazine Chemical compound OCCOCCN1CCNCC1 FLNQAPQQAZVRDA-UHFFFAOYSA-N 0.000 description 2
- RZPIFYNEFCYAOP-UHFFFAOYSA-N 1-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound CN1CCN(CC1)C1=CC=CC2=C1C1=C(NC3=C(N=C1)C=CC=C3)S2 RZPIFYNEFCYAOP-UHFFFAOYSA-N 0.000 description 2
- FXHRAKUEZPSMLJ-UHFFFAOYSA-N 1-methyl-1,4-diazepane Chemical compound CN1CCCNCC1 FXHRAKUEZPSMLJ-UHFFFAOYSA-N 0.000 description 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 2
- RXPTWCZPUWDDLG-UHFFFAOYSA-N 2,3-dimethyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C)=C2C RXPTWCZPUWDDLG-UHFFFAOYSA-N 0.000 description 2
- UVNYYSBACKWSFP-UHFFFAOYSA-N 2,7-dimethyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=C(C)C=C2NC(=O)C2=C1SC(C)=C2 UVNYYSBACKWSFP-UHFFFAOYSA-N 0.000 description 2
- JXKKFWTURRXZBN-UHFFFAOYSA-N 2,9-dimethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC(C)=C2OC2=C1C=C(C)S2 JXKKFWTURRXZBN-UHFFFAOYSA-N 0.000 description 2
- CMLNKSAEGMMNFS-UHFFFAOYSA-N 2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carbonitrile Chemical compound NC1=CC=C(F)C=C1NC1=C(C#N)C2=CC=CC=C2S1 CMLNKSAEGMMNFS-UHFFFAOYSA-N 0.000 description 2
- KJCRYAYREICHCZ-UHFFFAOYSA-N 2-(4-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC(F)=CC=C1NC1=C(C#N)C2=CC=CC=C2S1 KJCRYAYREICHCZ-UHFFFAOYSA-N 0.000 description 2
- IIDUNAVOCYMUFB-UHFFFAOYSA-N 2-amino-5-fluorophenol Chemical compound NC1=CC=C(F)C=C1O IIDUNAVOCYMUFB-UHFFFAOYSA-N 0.000 description 2
- VRVRGVPWCUEOGV-UHFFFAOYSA-N 2-aminothiophenol Chemical compound NC1=CC=CC=C1S VRVRGVPWCUEOGV-UHFFFAOYSA-N 0.000 description 2
- MRHCHEZVUNHHBL-UHFFFAOYSA-N 2-bromo-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid Chemical compound C1CCCC2=C1SC(Br)=C2C(=O)O MRHCHEZVUNHHBL-UHFFFAOYSA-N 0.000 description 2
- YTSXOSPFIWDJGQ-UHFFFAOYSA-N 2-bromo-5-methylthiophene-3-carbonyl chloride Chemical compound CC1=CC(C(Cl)=O)=C(Br)S1 YTSXOSPFIWDJGQ-UHFFFAOYSA-N 0.000 description 2
- QRILWZHPSVRWRA-UHFFFAOYSA-N 2-bromo-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(Br)=C2 QRILWZHPSVRWRA-UHFFFAOYSA-N 0.000 description 2
- PDIYHBOFLLRICO-UHFFFAOYSA-N 2-bromo-n-(4-fluoro-2-hydroxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC(F)=CC=2)O)=C1Br PDIYHBOFLLRICO-UHFFFAOYSA-N 0.000 description 2
- QDUDWDNKLUXTKI-UHFFFAOYSA-N 2-bromo-n-(4-fluoro-2-sulfanylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound SC1=CC(F)=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 QDUDWDNKLUXTKI-UHFFFAOYSA-N 0.000 description 2
- LFSDCRTUYZAWPX-UHFFFAOYSA-N 2-bromo-n-(4-methyl-2-sulfanylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound SC1=CC(C)=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 LFSDCRTUYZAWPX-UHFFFAOYSA-N 0.000 description 2
- FQSCMRLVULSCFH-UHFFFAOYSA-N 2-butyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(CCCC)=C2 FQSCMRLVULSCFH-UHFFFAOYSA-N 0.000 description 2
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 2
- WZMOWQCNPFDWPA-UHFFFAOYSA-N 2-fluoro-4-methyl-1-nitrobenzene Chemical compound CC1=CC=C([N+]([O-])=O)C(F)=C1 WZMOWQCNPFDWPA-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- OMWJSLKIVQDFLZ-UHFFFAOYSA-N 2-methyl-7-nitro-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=C([N+]([O-])=O)C=C2NC(=O)C2=C1SC(C)=C2 OMWJSLKIVQDFLZ-UHFFFAOYSA-N 0.000 description 2
- PNOWYVBMXYSRAD-UHFFFAOYSA-N 2-methyl-8-nitro-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC([N+]([O-])=O)=CC=C2NC(=O)C2=C1SC(C)=C2 PNOWYVBMXYSRAD-UHFFFAOYSA-N 0.000 description 2
- RRKWYOVRNXDVRH-UHFFFAOYSA-N 2-phenyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound C=1C=2C(=O)NC3=CC=CC=C3OC=2SC=1C1=CC=CC=C1 RRKWYOVRNXDVRH-UHFFFAOYSA-N 0.000 description 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 2
- GSAWTEZCBAXVCA-UHFFFAOYSA-N 2-prop-1-en-2-yl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(=C)C)=C2 GSAWTEZCBAXVCA-UHFFFAOYSA-N 0.000 description 2
- FOKQBOCUXYGMOW-UHFFFAOYSA-N 2-propan-2-yl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(C)C)=C2 FOKQBOCUXYGMOW-UHFFFAOYSA-N 0.000 description 2
- MHECHTRMDMIWQH-UHFFFAOYSA-N 2-propanoyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(=O)CC)=C2 MHECHTRMDMIWQH-UHFFFAOYSA-N 0.000 description 2
- AXLBXTKRIZHQRE-UHFFFAOYSA-N 2-propyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(CCC)=C2 AXLBXTKRIZHQRE-UHFFFAOYSA-N 0.000 description 2
- UMZYCRUSHNQHQS-UHFFFAOYSA-N 3,8-difluoro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=CC(F)=CC=C21 UMZYCRUSHNQHQS-UHFFFAOYSA-N 0.000 description 2
- YNSCKPCDFIDINW-UHFFFAOYSA-N 3-[[2-[[1-[2-(dimethylamino)acetyl]-6-methoxy-4,4-dimethyl-2,3-dihydroquinolin-7-yl]amino]-7h-pyrrolo[2,3-d]pyrimidin-4-yl]amino]thiophene-2-carboxamide Chemical compound COC1=CC(C(CCN2C(=O)CN(C)C)(C)C)=C2C=C1NC(N=C1NC=CC1=1)=NC=1NC=1C=CSC=1C(N)=O YNSCKPCDFIDINW-UHFFFAOYSA-N 0.000 description 2
- UJBOOUHRTQVGRU-UHFFFAOYSA-N 3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1 UJBOOUHRTQVGRU-UHFFFAOYSA-N 0.000 description 2
- VGVHNLRUAMRIEW-UHFFFAOYSA-N 4-methylcyclohexan-1-one Chemical compound CC1CCC(=O)CC1 VGVHNLRUAMRIEW-UHFFFAOYSA-N 0.000 description 2
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 description 2
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 description 2
- QDDGDCHXGAATCK-UHFFFAOYSA-N 5-methyl-1-benzothiophene-3-carboxylic acid Chemical compound CC1=CC=C2SC=C(C(O)=O)C2=C1 QDDGDCHXGAATCK-UHFFFAOYSA-N 0.000 description 2
- QLTRUEIUIIWRQC-UHFFFAOYSA-N 5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O=C1NC2=CC=CC=C2OC2=C1C=CS2 QLTRUEIUIIWRQC-UHFFFAOYSA-N 0.000 description 2
- VWFUBWYVCWTDJA-UHFFFAOYSA-N 6-chloro-2-(2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=CC=C1NC1=C(C#N)C2=CC=C(Cl)C=C2S1 VWFUBWYVCWTDJA-UHFFFAOYSA-N 0.000 description 2
- LGPZMCSOENSZPL-UHFFFAOYSA-N 6-methyl-1-benzothiophene-3-carboxylic acid Chemical compound CC1=CC=C2C(C(O)=O)=CSC2=C1 LGPZMCSOENSZPL-UHFFFAOYSA-N 0.000 description 2
- GHHBXDBVNMIFIS-UHFFFAOYSA-N 7-chloro-2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=C(Cl)C=C2NC(=O)C2=C1SC(C)=C2 GHHBXDBVNMIFIS-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- XVXBGCSZYQFGOF-UHFFFAOYSA-N 8,9-difluoro-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepin-12-amine hydron chloride Chemical compound Cl.NC1=NC2=CC(F)=C(F)C=C2NC2=C1C1=CC=CC=C1S2 XVXBGCSZYQFGOF-UHFFFAOYSA-N 0.000 description 2
- CTROTLNCESNVGB-UHFFFAOYSA-N 8-chloro-6,11-dihydro-[1]benzothiolo[3,2-c][1,5]benzodiazepin-12-one Chemical compound N1C2=CC(Cl)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 CTROTLNCESNVGB-UHFFFAOYSA-N 0.000 description 2
- ZTQUNZXEZWBSJK-UHFFFAOYSA-N 8-fluoro-12-piperazin-1-yl-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound S1C2=CC=CC=C2C2=C1NC1=CC(F)=CC=C1N=C2N1CCNCC1 ZTQUNZXEZWBSJK-UHFFFAOYSA-N 0.000 description 2
- DCNNKEJCLNYKAO-UHFFFAOYSA-N 8-methoxy-2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1=2C=C(C)SC=2OC2=CC(OC)=CC=C2N=C1N1CCN(C)CC1 DCNNKEJCLNYKAO-UHFFFAOYSA-N 0.000 description 2
- KEMXYJWUCVIGIO-UHFFFAOYSA-N 8-methyl-2,3,4,11-tetrahydro-1h-[1]benzothiolo[2,3-b][1,5]benzoxazepin-12-one Chemical compound O1C2=CC(C)=CC=C2NC(=O)C2=C1SC1=C2CCCC1 KEMXYJWUCVIGIO-UHFFFAOYSA-N 0.000 description 2
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 2
- IBKNGICWLNGHRN-SPIKMXEPSA-N C(\C=C/C(=O)O)(=O)O.C(\C=C/C(=O)O)(=O)O.N1C=CC=NC2=C1C=CC=C2 Chemical compound C(\C=C/C(=O)O)(=O)O.C(\C=C/C(=O)O)(=O)O.N1C=CC=NC2=C1C=CC=C2 IBKNGICWLNGHRN-SPIKMXEPSA-N 0.000 description 2
- MBMMOHYHTRACEC-UHFFFAOYSA-N Cl.NC=1C2=C(NC3=C(N1)C=CC=C3)SC3=C2C=CC(=C3)Cl Chemical compound Cl.NC=1C2=C(NC3=C(N1)C=CC=C3)SC3=C2C=CC(=C3)Cl MBMMOHYHTRACEC-UHFFFAOYSA-N 0.000 description 2
- PXRXJYBJPQNXRF-UHFFFAOYSA-N Cl.NC=1C2=C(NC3=C(N1)C=CC=C3)SC3=C2C=CC(=C3)F Chemical compound Cl.NC=1C2=C(NC3=C(N1)C=CC=C3)SC3=C2C=CC(=C3)F PXRXJYBJPQNXRF-UHFFFAOYSA-N 0.000 description 2
- XMHKHIKYRDVYKB-UHFFFAOYSA-N Cl.NC=1C2=C(NC3=C(N1)C=CC=C3)SC3=C2C=CC=C3C Chemical compound Cl.NC=1C2=C(NC3=C(N1)C=CC=C3)SC3=C2C=CC=C3C XMHKHIKYRDVYKB-UHFFFAOYSA-N 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 2
- XXUGWCQIWUBNIY-UHFFFAOYSA-N [1]benzothiolo[2,3-b][1,5]benzothiazepine Chemical compound C1=CC=CC2=C1C1=C(SC3=C(N=C1)C=CC=C3)S2 XXUGWCQIWUBNIY-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- RVSGRNKUJJUAPV-UHFFFAOYSA-N benzo[d][1,2]benzoxazepine Chemical class O1N=CC2=CC=CC=C2C2=CC=CC=C12 RVSGRNKUJJUAPV-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000007806 chemical reaction intermediate Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940045803 cuprous chloride Drugs 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- GRTGGSXWHGKRSB-UHFFFAOYSA-N dichloromethyl methyl ether Chemical compound COC(Cl)Cl GRTGGSXWHGKRSB-UHFFFAOYSA-N 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- KSVNPKXAMCDFOU-UHFFFAOYSA-N ethyl 2-(2-aminoanilino)-6-methoxy-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(OC)=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1N KSVNPKXAMCDFOU-UHFFFAOYSA-N 0.000 description 2
- MIGLNVQWMJSSTR-UHFFFAOYSA-N ethyl 2-(2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1[N+]([O-])=O MIGLNVQWMJSSTR-UHFFFAOYSA-N 0.000 description 2
- QAFXCLVKCVHMPV-UHFFFAOYSA-N ethyl 2-(5-chloro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(Cl)=CC=C1[N+]([O-])=O QAFXCLVKCVHMPV-UHFFFAOYSA-N 0.000 description 2
- JAJMMVCLXOKJOX-UHFFFAOYSA-N ethyl 2-(6-amino-2,3-dichloroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=C(N)C=CC(Cl)=C1Cl JAJMMVCLXOKJOX-UHFFFAOYSA-N 0.000 description 2
- IWVMBAUTNRSMEI-UHFFFAOYSA-N ethyl 2-amino-6-methoxy-1-benzothiophene-3-carboxylate Chemical compound COC1=CC=C2C(C(=O)OCC)=C(N)SC2=C1 IWVMBAUTNRSMEI-UHFFFAOYSA-N 0.000 description 2
- RVJAKQJEJNVOCC-UHFFFAOYSA-N ethyl 2-amino-6-methyl-1-benzothiophene-3-carboxylate Chemical compound CC1=CC=C2C(C(=O)OCC)=C(N)SC2=C1 RVJAKQJEJNVOCC-UHFFFAOYSA-N 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960004275 glycolic acid Drugs 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 150000002688 maleic acid derivatives Chemical class 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- PFRZKSQRSJESHT-UHFFFAOYSA-N methyl 2-(2-aminoanilino)-5-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=C(C)C=C2C(C(=O)OC)=C1NC1=CC=CC=C1N PFRZKSQRSJESHT-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- 230000002887 neurotoxic effect Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 2
- 229960005235 piperonyl butoxide Drugs 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- GRJJQCWNZGRKAU-UHFFFAOYSA-N pyridin-1-ium;fluoride Chemical compound F.C1=CC=NC=C1 GRJJQCWNZGRKAU-UHFFFAOYSA-N 0.000 description 2
- 229910052701 rubidium Inorganic materials 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- CLURAKRVQIPBCC-UHFFFAOYSA-M sodium;perbromate Chemical compound [Na+].[O-]Br(=O)(=O)=O CLURAKRVQIPBCC-UHFFFAOYSA-M 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- DAUYIKBTMNZABP-UHFFFAOYSA-N thiophene-3-carboxamide Chemical compound NC(=O)C=1C=CSC=1 DAUYIKBTMNZABP-UHFFFAOYSA-N 0.000 description 2
- YNVOMSDITJMNET-UHFFFAOYSA-M thiophene-3-carboxylate Chemical compound [O-]C(=O)C=1C=CSC=1 YNVOMSDITJMNET-UHFFFAOYSA-M 0.000 description 2
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 2
- GKYPJLUHGAJKEM-UHFFFAOYSA-N tin;dihydrate Chemical compound O.O.[Sn] GKYPJLUHGAJKEM-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- KOKSPPLVDBNREC-SPIKMXEPSA-N (Z)-but-2-enedioic acid 2-ethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.S1C(CC)=CC2=C1OC1=CC=CC=C1N=C2N1CCN(C)CC1 KOKSPPLVDBNREC-SPIKMXEPSA-N 0.000 description 1
- KZEQEEXRYJNOBG-WLHGVMLRSA-N (e)-but-2-enedioic acid;2-butyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound OC(=O)\C=C\C(O)=O.S1C(CCCC)=CC2=C1OC1=CC=CC=C1N=C2N1CCN(C)CC1 KZEQEEXRYJNOBG-WLHGVMLRSA-N 0.000 description 1
- JLKGJHPTCHQNLB-WLHGVMLRSA-N (e)-but-2-enedioic acid;8-methoxy-2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound OC(=O)\C=C\C(O)=O.C1=2C=C(C)SC=2OC2=CC(OC)=CC=C2N=C1N1CCN(C)CC1 JLKGJHPTCHQNLB-WLHGVMLRSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- BGKIECJVXXHLDP-UHFFFAOYSA-N 1,2,3-trichloro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C(Cl)=C1Cl BGKIECJVXXHLDP-UHFFFAOYSA-N 0.000 description 1
- IBRBMZRLVYKVRF-UHFFFAOYSA-N 1,2,4-trichloro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Cl)=C(Cl)C=C1Cl IBRBMZRLVYKVRF-UHFFFAOYSA-N 0.000 description 1
- ZCXLTWVZYXBHJS-UHFFFAOYSA-N 1,2-benzoxazepine Chemical compound O1N=CC=CC2=CC=CC=C12 ZCXLTWVZYXBHJS-UHFFFAOYSA-N 0.000 description 1
- BARLPBPUTCZWPM-WLHGVMLRSA-N 1,2-benzoxazepine;(e)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.O1N=CC=CC2=CC=CC=C12 BARLPBPUTCZWPM-WLHGVMLRSA-N 0.000 description 1
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 1
- 229940005561 1,4-benzoquinone Drugs 0.000 description 1
- WRGKKASJBOREMB-UHFFFAOYSA-N 1,4-dibromo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Br)=CC=C1Br WRGKKASJBOREMB-UHFFFAOYSA-N 0.000 description 1
- RZKKOBGFCAHLCZ-UHFFFAOYSA-N 1,4-dichloro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC=C1Cl RZKKOBGFCAHLCZ-UHFFFAOYSA-N 0.000 description 1
- RAVKDBINTWOXDN-UHFFFAOYSA-N 1,5-benzoxazepine Chemical compound O1C=CC=NC2=CC=CC=C12 RAVKDBINTWOXDN-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- RSNPXSXDRKSDOA-UHFFFAOYSA-N 1-[4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepin-2-yl]ethanone Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=C1C=C(C(C)=O)S2 RSNPXSXDRKSDOA-UHFFFAOYSA-N 0.000 description 1
- LLAPDLPYIYKTGQ-UHFFFAOYSA-N 1-aminoethyl Chemical group C[CH]N LLAPDLPYIYKTGQ-UHFFFAOYSA-N 0.000 description 1
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical compound C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 description 1
- BFCFYVKQTRLZHA-UHFFFAOYSA-N 1-chloro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1Cl BFCFYVKQTRLZHA-UHFFFAOYSA-N 0.000 description 1
- HNZJIWIXRPBFAN-UHFFFAOYSA-N 1-cyclopropylpiperazine Chemical compound C1CC1N1CCNCC1 HNZJIWIXRPBFAN-UHFFFAOYSA-N 0.000 description 1
- WGCYRFWNGRMRJA-UHFFFAOYSA-N 1-ethylpiperazine Chemical compound CCN1CCNCC1 WGCYRFWNGRMRJA-UHFFFAOYSA-N 0.000 description 1
- HLDFCCHSOZWKAA-UHFFFAOYSA-N 1-fluoro-2-nitro-4-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1F HLDFCCHSOZWKAA-UHFFFAOYSA-N 0.000 description 1
- ZRIKJXDEJYMBEJ-UHFFFAOYSA-N 1-fluoro-4-methoxy-2-nitrobenzene Chemical compound COC1=CC=C(F)C([N+]([O-])=O)=C1 ZRIKJXDEJYMBEJ-UHFFFAOYSA-N 0.000 description 1
- OORBDHOQLZRIQR-UHFFFAOYSA-N 1-fluoro-4-methyl-2-nitrobenzene Chemical compound CC1=CC=C(F)C([N+]([O-])=O)=C1 OORBDHOQLZRIQR-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- WHKWMTXTYKVFLK-UHFFFAOYSA-N 1-propan-2-ylpiperazine Chemical compound CC(C)N1CCNCC1 WHKWMTXTYKVFLK-UHFFFAOYSA-N 0.000 description 1
- KPMPUVVLGGCJKY-UHFFFAOYSA-N 12-(4-methylpiperazin-1-yl)-9-(trifluoromethyl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC(C(F)(F)F)=CC=C2NC2=C1C1=CC=CC=C1S2 KPMPUVVLGGCJKY-UHFFFAOYSA-N 0.000 description 1
- VCHQOMZHSVSMOM-UHFFFAOYSA-N 12-(4-methylpiperazin-1-yl)-[1]benzothiolo[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=C1C1=CC=CC=C1S2 VCHQOMZHSVSMOM-UHFFFAOYSA-N 0.000 description 1
- OMWIVVBFLHFASJ-UHFFFAOYSA-N 1h-1,2-benzodiazepin-1-ium;chloride Chemical compound Cl.N1N=CC=CC2=CC=CC=C12 OMWIVVBFLHFASJ-UHFFFAOYSA-N 0.000 description 1
- IKPCZIDHBPJYAA-UHFFFAOYSA-N 1h-1,2-benzodiazepine;dihydrochloride Chemical compound Cl.Cl.N1N=CC=CC2=CC=CC=C12 IKPCZIDHBPJYAA-UHFFFAOYSA-N 0.000 description 1
- FGFBEHFJSQBISW-UHFFFAOYSA-N 1h-cyclopenta[b]pyridine Chemical compound C1=CNC2=CC=CC2=C1 FGFBEHFJSQBISW-UHFFFAOYSA-N 0.000 description 1
- NPJUWQOZDGNZBE-UHFFFAOYSA-N 2,2-diethylcyclohexan-1-one Chemical compound CCC1(CC)CCCCC1=O NPJUWQOZDGNZBE-UHFFFAOYSA-N 0.000 description 1
- WXBNWIPBGKDTQY-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1-benzothiophene-3-carboxylic acid Chemical compound C1=CCC2C(C(=O)O)CSC2=C1 WXBNWIPBGKDTQY-UHFFFAOYSA-N 0.000 description 1
- DXRVYZGVVFZCFP-UHFFFAOYSA-N 2,4-dibromo-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Br)C=C1Br DXRVYZGVVFZCFP-UHFFFAOYSA-N 0.000 description 1
- QUIMTLZDMCNYGY-UHFFFAOYSA-N 2,4-dichloro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1Cl QUIMTLZDMCNYGY-UHFFFAOYSA-N 0.000 description 1
- CZZZABOKJQXEBO-UHFFFAOYSA-N 2,4-dimethylaniline Chemical compound CC1=CC=C(N)C(C)=C1 CZZZABOKJQXEBO-UHFFFAOYSA-N 0.000 description 1
- POEDHCFTCQNEAQ-UHFFFAOYSA-N 2,4-dimethylthiophene-3-carboxamide Chemical compound CC1=CSC(C)=C1C(N)=O POEDHCFTCQNEAQ-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- RCUISCLKUPFARM-UHFFFAOYSA-N 2-(4,5-difluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC(F)=C(F)C=C1NC1=C(C#N)C2=CC=CC=C2S1 RCUISCLKUPFARM-UHFFFAOYSA-N 0.000 description 1
- WTEGMBXIKULAJP-UHFFFAOYSA-N 2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1NC1=C(C#N)C2=CC=CC=C2S1 WTEGMBXIKULAJP-UHFFFAOYSA-N 0.000 description 1
- LUSKKLJWMBHKEJ-UHFFFAOYSA-N 2-(5-fluoro-2-nitroanilino)-6-methoxy-1-benzothiophene-3-carbonitrile Chemical compound S1C2=CC(OC)=CC=C2C(C#N)=C1NC1=CC(F)=CC=C1[N+]([O-])=O LUSKKLJWMBHKEJ-UHFFFAOYSA-N 0.000 description 1
- DYZBITSETXEHAL-UHFFFAOYSA-N 2-(hydroxymethyl)-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(CO)=C2 DYZBITSETXEHAL-UHFFFAOYSA-N 0.000 description 1
- VLZVIIYRNMWPSN-UHFFFAOYSA-N 2-Amino-4-nitrophenol Chemical compound NC1=CC([N+]([O-])=O)=CC=C1O VLZVIIYRNMWPSN-UHFFFAOYSA-N 0.000 description 1
- DOPJTDJKZNWLRB-UHFFFAOYSA-N 2-Amino-5-nitrophenol Chemical compound NC1=CC=C([N+]([O-])=O)C=C1O DOPJTDJKZNWLRB-UHFFFAOYSA-N 0.000 description 1
- WGOVJGWJECGQRL-UHFFFAOYSA-N 2-[(dimethylamino)methyl]-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(CN(C)C)=C2 WGOVJGWJECGQRL-UHFFFAOYSA-N 0.000 description 1
- FEDLEBCVFZMHBP-UHFFFAOYSA-N 2-amino-3-methylphenol Chemical compound CC1=CC=CC(O)=C1N FEDLEBCVFZMHBP-UHFFFAOYSA-N 0.000 description 1
- ULDFRPKVIZMKJG-UHFFFAOYSA-N 2-amino-4-fluorophenol Chemical compound NC1=CC(F)=CC=C1O ULDFRPKVIZMKJG-UHFFFAOYSA-N 0.000 description 1
- HERKXOIBIXCBST-UHFFFAOYSA-N 2-amino-4-methyl-1-benzothiophene-3-carbonitrile Chemical compound CC1=CC=CC2=C1C(C#N)=C(N)S2 HERKXOIBIXCBST-UHFFFAOYSA-N 0.000 description 1
- UPEWNVDJDYMWIV-UHFFFAOYSA-N 2-amino-5-fluorobenzenethiol Chemical compound NC1=CC=C(F)C=C1S UPEWNVDJDYMWIV-UHFFFAOYSA-N 0.000 description 1
- AOWNYDDZDLTCGB-UHFFFAOYSA-N 2-amino-5-methoxyphenol Chemical compound COC1=CC=C(N)C(O)=C1 AOWNYDDZDLTCGB-UHFFFAOYSA-N 0.000 description 1
- VUMZNLOQJGKGNE-UHFFFAOYSA-N 2-amino-5-methylbenzenethiol Chemical compound CC1=CC=C(N)C(S)=C1 VUMZNLOQJGKGNE-UHFFFAOYSA-N 0.000 description 1
- HCPJEHJGFKWRFM-UHFFFAOYSA-N 2-amino-5-methylphenol Chemical compound CC1=CC=C(N)C(O)=C1 HCPJEHJGFKWRFM-UHFFFAOYSA-N 0.000 description 1
- GWXIGCZEXDVFDN-UHFFFAOYSA-N 2-amino-6-methoxyphenol;hydrochloride Chemical compound Cl.COC1=CC=CC(N)=C1O GWXIGCZEXDVFDN-UHFFFAOYSA-N 0.000 description 1
- ZHTFYPKGKJWHNH-UHFFFAOYSA-N 2-amino-6-methyl-1-benzothiophene-3-carboxylic acid Chemical compound CC1=CC=C2C(C(O)=O)=C(N)SC2=C1 ZHTFYPKGKJWHNH-UHFFFAOYSA-N 0.000 description 1
- ALQKEYVDQYGZDN-UHFFFAOYSA-N 2-amino-6-methylphenol Chemical compound CC1=CC=CC(N)=C1O ALQKEYVDQYGZDN-UHFFFAOYSA-N 0.000 description 1
- ZMXYNJXDULEQCK-UHFFFAOYSA-N 2-amino-p-cresol Chemical compound CC1=CC=C(O)C(N)=C1 ZMXYNJXDULEQCK-UHFFFAOYSA-N 0.000 description 1
- VPLITVQPROCSGC-UHFFFAOYSA-N 2-bromo-4,5-dimethylthiophene-3-carboxylic acid Chemical compound CC=1SC(Br)=C(C(O)=O)C=1C VPLITVQPROCSGC-UHFFFAOYSA-N 0.000 description 1
- UHBVOYZUTBXFEC-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-3-methylphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=C(C)C=CC=2)O)=C1Br UHBVOYZUTBXFEC-UHFFFAOYSA-N 0.000 description 1
- AOHGCLLPABQAKW-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-methoxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound OC1=CC(OC)=CC=C1NC(=O)C1=C(Br)SC(C)=C1 AOHGCLLPABQAKW-UHFFFAOYSA-N 0.000 description 1
- XOUQLULTOLZSLZ-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-methylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound OC1=CC(C)=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 XOUQLULTOLZSLZ-UHFFFAOYSA-N 0.000 description 1
- PIGRXBLQJMBRND-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-methylphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC(C)=CC=2)O)=C1Br PIGRXBLQJMBRND-UHFFFAOYSA-N 0.000 description 1
- IIRJIHAEWMNCAT-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-nitrophenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC(=CC=2)[N+]([O-])=O)O)=C1Br IIRJIHAEWMNCAT-UHFFFAOYSA-N 0.000 description 1
- UBKLVDSMEYZYLQ-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-5-nitrophenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC=C(C=2)[N+]([O-])=O)O)=C1Br UBKLVDSMEYZYLQ-UHFFFAOYSA-N 0.000 description 1
- UISZREWDZBZFRY-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-6-methylphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC=CC=2C)O)=C1Br UISZREWDZBZFRY-UHFFFAOYSA-N 0.000 description 1
- NBIZOERPLUNAFF-UHFFFAOYSA-N 2-bromo-n-(2-hydroxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound OC1=CC=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 NBIZOERPLUNAFF-UHFFFAOYSA-N 0.000 description 1
- STIIWLOSNDCLKU-UHFFFAOYSA-N 2-bromo-n-(2-hydroxyphenyl)thiophene-3-carboxamide Chemical compound OC1=CC=CC=C1NC(=O)C1=C(Br)SC=C1 STIIWLOSNDCLKU-UHFFFAOYSA-N 0.000 description 1
- KDCUQZOUZUEQJN-UHFFFAOYSA-N 2-bromo-n-(4-chloro-2-hydroxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC(Cl)=CC=2)O)=C1Br KDCUQZOUZUEQJN-UHFFFAOYSA-N 0.000 description 1
- XBKRCAMXZKWVRS-UHFFFAOYSA-N 2-bromo-n-(4-fluoro-2-hydroxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound OC1=CC(F)=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 XBKRCAMXZKWVRS-UHFFFAOYSA-N 0.000 description 1
- ZNAHUHLSZGPUCY-UHFFFAOYSA-N 2-bromo-n-(5-fluoro-2-hydroxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC=C(F)C=2)O)=C1Br ZNAHUHLSZGPUCY-UHFFFAOYSA-N 0.000 description 1
- RVSXMPCELBYUSF-UHFFFAOYSA-N 2-bromothiophene-3-carboxylic acid Chemical compound OC(=O)C=1C=CSC=1Br RVSXMPCELBYUSF-UHFFFAOYSA-N 0.000 description 1
- BEGNSDBJAQDAOD-UHFFFAOYSA-N 2-butanoyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(=O)CCC)=C2 BEGNSDBJAQDAOD-UHFFFAOYSA-N 0.000 description 1
- MGXFNZZLZMCAHA-UHFFFAOYSA-N 2-ethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound S1C(CC)=CC2=C1OC1=CC=CC=C1N=C2N1CCN(C)CC1 MGXFNZZLZMCAHA-UHFFFAOYSA-N 0.000 description 1
- LRZSAGKIMYFLHY-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;dihydrate Chemical compound O.O.OC(=O)CC(O)(C(O)=O)CC(O)=O LRZSAGKIMYFLHY-UHFFFAOYSA-N 0.000 description 1
- UMGIPSWDNUNNQF-UHFFFAOYSA-N 2-methyl-4-(4-methyl-1,4-diazepan-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCCN1C1=NC2=CC=CC=C2OC2=C1C=C(C)S2 UMGIPSWDNUNNQF-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- IWUWYCZJMZHSKG-UHFFFAOYSA-N 3-fluoro-8-methyl-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-12-amine Chemical compound N1C2=CC(C)=CC=C2N=C(N)C2=C1SC1=CC(F)=CC=C21 IWUWYCZJMZHSKG-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- OUBUUZCKCDMLNY-UHFFFAOYSA-N 4-methyl-2-(2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound N#CC=1C=2C(C)=CC=CC=2SC=1NC1=CC=CC=C1[N+]([O-])=O OUBUUZCKCDMLNY-UHFFFAOYSA-N 0.000 description 1
- DWXHFDGIYRGHOG-UHFFFAOYSA-N 4-oxo-5h-thieno[2,3-b][1,5]benzoxazepine-2-carbaldehyde Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C=O)=C2 DWXHFDGIYRGHOG-UHFFFAOYSA-N 0.000 description 1
- DDMJYHKSLSZRPF-UHFFFAOYSA-N 5-bromo-n-(2-hydroxyphenyl)thiophene-3-carboxamide Chemical compound OC1=CC=CC=C1NC(=O)C1=CSC(Br)=C1 DDMJYHKSLSZRPF-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- AZMBEEBVOTUYAD-UHFFFAOYSA-N 6-fluoro-2-(2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=CC=C1NC1=C(C#N)C2=CC=C(F)C=C2S1 AZMBEEBVOTUYAD-UHFFFAOYSA-N 0.000 description 1
- NWACFUIXVJSSTQ-UHFFFAOYSA-N 6-fluoro-2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1NC1=C(C#N)C2=CC=C(F)C=C2S1 NWACFUIXVJSSTQ-UHFFFAOYSA-N 0.000 description 1
- PVZLBXQZTADBMA-UHFFFAOYSA-N 6-fluoro-2-(5-methyl-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound CC1=CC=C([N+]([O-])=O)C(NC2=C(C3=CC=C(F)C=C3S2)C#N)=C1 PVZLBXQZTADBMA-UHFFFAOYSA-N 0.000 description 1
- ZHTNKGUDSUGTBY-UHFFFAOYSA-N 6-methoxy-1-benzothiophene-3-carboxylic acid Chemical compound COC1=CC=C2C(C(O)=O)=CSC2=C1 ZHTNKGUDSUGTBY-UHFFFAOYSA-N 0.000 description 1
- AQTCOECGSUXZSL-UHFFFAOYSA-N 7-fluoro-2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=C(F)C=C2NC(=O)C2=C1SC(C)=C2 AQTCOECGSUXZSL-UHFFFAOYSA-N 0.000 description 1
- FQKDKKBWCDEXLT-UHFFFAOYSA-N 7-methyl-2-(2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound S1C=2C(C)=CC=CC=2C(C#N)=C1NC1=CC=CC=C1[N+]([O-])=O FQKDKKBWCDEXLT-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- MGDNVSWHFNDAHF-UHFFFAOYSA-N 8-(chloromethyl)-3-fluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(CCl)C=C2NC2=C1C1=CC=C(F)C=C1S2 MGDNVSWHFNDAHF-UHFFFAOYSA-N 0.000 description 1
- JNHKMWUPZPHRER-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-[1]benzothiolo[2,3-b][1,5]benzothiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2SC2=C1C(CCCC1)=C1S2 JNHKMWUPZPHRER-UHFFFAOYSA-N 0.000 description 1
- DVQJRHFLHLEIPU-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-[1]benzothiolo[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2OC2=C1C(CCCC1)=C1S2 DVQJRHFLHLEIPU-UHFFFAOYSA-N 0.000 description 1
- DKQRJQUYRCXJOG-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepin-7-ol Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C(O)=C2NC2=C1C1=CC=CC=C1S2 DKQRJQUYRCXJOG-UHFFFAOYSA-N 0.000 description 1
- ITQZEXODWHOVRY-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepin-9-ol Chemical compound C1CN(C)CCN1C1=NC2=CC(O)=C(F)C=C2NC2=C1C1=CC=CC=C1S2 ITQZEXODWHOVRY-UHFFFAOYSA-N 0.000 description 1
- BCHVCBQDUBBSSU-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-1-ol Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=C(O)C=CC=C1S2 BCHVCBQDUBBSSU-UHFFFAOYSA-N 0.000 description 1
- VVSLZUDQKCPPJW-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-10-ol Chemical compound C1CN(C)CCN1C1=NC2=C(O)C=C(F)C=C2NC2=C1C1=CC=CC=C1S2 VVSLZUDQKCPPJW-UHFFFAOYSA-N 0.000 description 1
- OMKOLCPAGLVSIC-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-2-ol Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC(O)=CC=C1S2 OMKOLCPAGLVSIC-UHFFFAOYSA-N 0.000 description 1
- CAVXRQBOWXYJRW-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-3-ol Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=C(O)C=C1S2 CAVXRQBOWXYJRW-UHFFFAOYSA-N 0.000 description 1
- BMCOPDRCTONYCT-UHFFFAOYSA-N 8-fluoro-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-4-ol Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=CC(O)=C1S2 BMCOPDRCTONYCT-UHFFFAOYSA-N 0.000 description 1
- IOBPUJKOARTJHC-UHFFFAOYSA-N 8-fluoro-12-(4-propan-2-ylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C(C)C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=CC=C1S2 IOBPUJKOARTJHC-UHFFFAOYSA-N 0.000 description 1
- MSJRJGDUFDRBQV-UHFFFAOYSA-N 8-methyl-12-(4-methylpiperazin-1-yl)-[1]benzothiolo[2,3-b][1,5]benzothiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(C)C=C2SC2=C1C1=CC=CC=C1S2 MSJRJGDUFDRBQV-UHFFFAOYSA-N 0.000 description 1
- HVZKHPCHOPXKKL-UHFFFAOYSA-N 9-fluoro-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepin-12-amine hydrochloride Chemical compound Cl.NC1=NC2=CC(F)=CC=C2NC2=C1C1=CC=CC=C1S2 HVZKHPCHOPXKKL-UHFFFAOYSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 206010001540 Akathisia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- GBHFMPNIHOGUJC-UHFFFAOYSA-N C(C=C/C(=O)O)(=O)O.C(C=C/C(=O)O)(=O)O.O1N=CC=CC2=C1C=CC=C2 Chemical compound C(C=C/C(=O)O)(=O)O.C(C=C/C(=O)O)(=O)O.O1N=CC=CC2=C1C=CC=C2 GBHFMPNIHOGUJC-UHFFFAOYSA-N 0.000 description 1
- VZSGNQQCKWYXBD-WLHGVMLRSA-N C(\C=C\C(=O)O)(=O)O.O1C=CC=NC2=C1C=CC=C2 Chemical compound C(\C=C\C(=O)O)(=O)O.O1C=CC=NC2=C1C=CC=C2 VZSGNQQCKWYXBD-WLHGVMLRSA-N 0.000 description 1
- WCRDRCKVDOWWCQ-UHFFFAOYSA-N C1=CC=C2C(=C1)C3=C(S2)OC4=CC=CC=C4N=C3 Chemical compound C1=CC=C2C(=C1)C3=C(S2)OC4=CC=CC=C4N=C3 WCRDRCKVDOWWCQ-UHFFFAOYSA-N 0.000 description 1
- BGVFECSPCGMEBB-UHFFFAOYSA-N C1=CC=C2C(=C1)N=CC3=C(O2)SC(=C3)Br Chemical compound C1=CC=C2C(=C1)N=CC3=C(O2)SC(=C3)Br BGVFECSPCGMEBB-UHFFFAOYSA-N 0.000 description 1
- RCIYKISZIIILSY-UHFFFAOYSA-N CN(CC1)CCN1C1=CC=CC2=C1C(C=NC(C=CC=C1)=C1O1)=C1S2 Chemical compound CN(CC1)CCN1C1=CC=CC2=C1C(C=NC(C=CC=C1)=C1O1)=C1S2 RCIYKISZIIILSY-UHFFFAOYSA-N 0.000 description 1
- 208000009132 Catalepsy Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FYNRFXQBQNMJSV-UHFFFAOYSA-N Cl.FC1=CC2=C(N=C(C3=C(N2)SC2=C3C=CC=C2)N2CCN(CC2)C)C=C1 Chemical compound Cl.FC1=CC2=C(N=C(C3=C(N2)SC2=C3C=CC=C2)N2CCN(CC2)C)C=C1 FYNRFXQBQNMJSV-UHFFFAOYSA-N 0.000 description 1
- TYHYJCJGOXETKH-UHFFFAOYSA-N Cl.NC=1C2=C(NC3=C(N1)C=CC(=C3)C)SC3=C2C=CC(=C3)F Chemical compound Cl.NC=1C2=C(NC3=C(N1)C=CC(=C3)C)SC3=C2C=CC(=C3)F TYHYJCJGOXETKH-UHFFFAOYSA-N 0.000 description 1
- CTJYEDHPQYOHRU-UHFFFAOYSA-N Cl.NC=1C2=C(NC3=C(N1)C=CC(=C3)F)SC3=C2C=CC(=C3)F Chemical compound Cl.NC=1C2=C(NC3=C(N1)C=CC(=C3)F)SC3=C2C=CC(=C3)F CTJYEDHPQYOHRU-UHFFFAOYSA-N 0.000 description 1
- NYJQYFSDJLFHAX-UHFFFAOYSA-N Cl.NC=1C2=C(NC3=C(N1)C=CC(=C3)F)SC3=C2C=CC(=C3)OC Chemical compound Cl.NC=1C2=C(NC3=C(N1)C=CC(=C3)F)SC3=C2C=CC(=C3)OC NYJQYFSDJLFHAX-UHFFFAOYSA-N 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012239 Delusion Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- STZHHWCLEMITME-SPIKMXEPSA-N OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.C1CN(C)CCN1C1=NC2=CC(F)=CC=C2OC2=C1C=C(C)S2 Chemical compound OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.C1CN(C)CCN1C1=NC2=CC(F)=CC=C2OC2=C1C=C(C)S2 STZHHWCLEMITME-SPIKMXEPSA-N 0.000 description 1
- FMAHYVCCNWPRKX-UHFFFAOYSA-N OCCOCCN(CC1)CCN1C1=CC=CC2=C1C(C=NC(C=CC=C1)=C1N1)=C1S2 Chemical compound OCCOCCN(CC1)CCN1C1=CC=CC2=C1C(C=NC(C=CC=C1)=C1N1)=C1S2 FMAHYVCCNWPRKX-UHFFFAOYSA-N 0.000 description 1
- 102100026450 POU domain, class 3, transcription factor 4 Human genes 0.000 description 1
- 101710133389 POU domain, class 3, transcription factor 4 Proteins 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010037180 Psychiatric symptoms Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 206010041243 Social avoidant behaviour Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 description 1
- AVRWEULSKHQETA-UHFFFAOYSA-N Thiophene-2 Chemical compound S1C=2CCCCCC=2C(C(=O)OC)=C1NC(=O)C1=C(F)C(F)=C(F)C(F)=C1F AVRWEULSKHQETA-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 206010047853 Waxy flexibility Diseases 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- MOQOOKGPCBQMCY-UHFFFAOYSA-N acetic acid;hexane Chemical compound CC(O)=O.CCCCCC MOQOOKGPCBQMCY-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- CGBYBGVMDAPUIH-UHFFFAOYSA-N acide dimethylmaleique Natural products OC(=O)C(C)=C(C)C(O)=O CGBYBGVMDAPUIH-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003354 anti-apomorphinic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 208000018300 basal ganglia disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 125000001626 borono group Chemical group [H]OB([*])O[H] 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- FIMJSWFMQJGVAM-UHFFFAOYSA-N chloroform;hydrate Chemical compound O.ClC(Cl)Cl FIMJSWFMQJGVAM-UHFFFAOYSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 231100000868 delusion Toxicity 0.000 description 1
- 150000008509 dibenzothiazepines Chemical class 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 238000001362 electron spin resonance spectrum Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- QMOWSXPVRZVEQZ-UHFFFAOYSA-N ethyl 2-(2-amino-4,5-dichloroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(Cl)=C(Cl)C=C1N QMOWSXPVRZVEQZ-UHFFFAOYSA-N 0.000 description 1
- ZUGGKNNHJQTQNS-UHFFFAOYSA-N ethyl 2-(2-amino-4,5-difluoroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=C(F)C=C1N ZUGGKNNHJQTQNS-UHFFFAOYSA-N 0.000 description 1
- CUWFNNQAXFZUJN-UHFFFAOYSA-N ethyl 2-(2-amino-4-chloroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(Cl)C=C1N CUWFNNQAXFZUJN-UHFFFAOYSA-N 0.000 description 1
- IMCDWXIAMGKOSP-UHFFFAOYSA-N ethyl 2-(2-amino-4-methylanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(C)C=C1N IMCDWXIAMGKOSP-UHFFFAOYSA-N 0.000 description 1
- AXMZTUJGKOVBTD-UHFFFAOYSA-N ethyl 2-(2-amino-5-fluoroanilino)-6-bromo-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(Br)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1N AXMZTUJGKOVBTD-UHFFFAOYSA-N 0.000 description 1
- LGHMKSYKHRFSSO-UHFFFAOYSA-N ethyl 2-(2-amino-5-fluoroanilino)-6-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(C)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1N LGHMKSYKHRFSSO-UHFFFAOYSA-N 0.000 description 1
- CBHIGKFYVWIYNZ-UHFFFAOYSA-N ethyl 2-(2-aminoanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1N CBHIGKFYVWIYNZ-UHFFFAOYSA-N 0.000 description 1
- KVVVVBZDNQHBAZ-UHFFFAOYSA-N ethyl 2-(3,5-difluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC(F)=C1[N+]([O-])=O KVVVVBZDNQHBAZ-UHFFFAOYSA-N 0.000 description 1
- OAJABPBNNASBFC-UHFFFAOYSA-N ethyl 2-amino-6-bromo-1-benzothiophene-3-carboxylate Chemical compound BrC1=CC=C2C(C(=O)OCC)=C(N)SC2=C1 OAJABPBNNASBFC-UHFFFAOYSA-N 0.000 description 1
- KRHUTJDRKGFWQD-UHFFFAOYSA-N ethyl 2-bromo-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate Chemical compound C1CCCC2=C1SC(Br)=C2C(=O)OCC KRHUTJDRKGFWQD-UHFFFAOYSA-N 0.000 description 1
- KXOLGQFXAGTKEC-UHFFFAOYSA-N ethyl 6-bromo-2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(Br)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1[N+]([O-])=O KXOLGQFXAGTKEC-UHFFFAOYSA-N 0.000 description 1
- LVGPCELNQXKDGG-UHFFFAOYSA-N ethyl 6-methyl-2-(2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(C)=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1[N+]([O-])=O LVGPCELNQXKDGG-UHFFFAOYSA-N 0.000 description 1
- AZLPEJUVWWGLHA-UHFFFAOYSA-N ethyl acetate;hexane;methanol Chemical compound OC.CCCCCC.CCOC(C)=O AZLPEJUVWWGLHA-UHFFFAOYSA-N 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- KIDXHMTZGRXJHE-UHFFFAOYSA-N ethyl acetate;methanol;2-propan-2-yloxypropane Chemical compound OC.CCOC(C)=O.CC(C)OC(C)C KIDXHMTZGRXJHE-UHFFFAOYSA-N 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- LOHNKDNSGRNHMD-UHFFFAOYSA-N methyl 5-methyl-2-(2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=C(C)C=C2C(C(=O)OC)=C1NC1=CC=CC=C1[N+]([O-])=O LOHNKDNSGRNHMD-UHFFFAOYSA-N 0.000 description 1
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- MQWCXKGKQLNYQG-UHFFFAOYSA-N methyl cyclohexan-4-ol Natural products CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 239000012022 methylating agents Substances 0.000 description 1
- HVOYZOQVDYHUPF-UHFFFAOYSA-N n,n',n'-trimethylethane-1,2-diamine Chemical compound CNCCN(C)C HVOYZOQVDYHUPF-UHFFFAOYSA-N 0.000 description 1
- FFVVZSZWSDHHEE-UHFFFAOYSA-N n,n-dimethyl-1-[4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepin-2-yl]methanamine Chemical compound S1C(CN(C)C)=CC2=C1OC1=CC=CC=C1N=C2N1CCN(C)CC1 FFVVZSZWSDHHEE-UHFFFAOYSA-N 0.000 description 1
- JIKUXBYRTXDNIY-UHFFFAOYSA-N n-methyl-n-phenylformamide Chemical compound O=CN(C)C1=CC=CC=C1 JIKUXBYRTXDNIY-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000009482 neurophysiological abnormality Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 229950010883 phencyclidine Drugs 0.000 description 1
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- ZTHJULTYCAQOIJ-WXXKFALUSA-N quetiapine fumarate Chemical compound [H+].[H+].[O-]C(=O)\C=C\C([O-])=O.C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12.C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 ZTHJULTYCAQOIJ-WXXKFALUSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960001534 risperidone Drugs 0.000 description 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
- 230000000698 schizophrenic effect Effects 0.000 description 1
- 229940035004 seroquel Drugs 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- GSXCEVHRIVLFJV-UHFFFAOYSA-N thiophene-3-carbonitrile Chemical compound N#CC=1C=CSC=1 GSXCEVHRIVLFJV-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- HTSABYAWKQAHBT-UHFFFAOYSA-N trans 3-methylcyclohexanol Natural products CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23670097 | 1997-09-02 | ||
| JP9-236700 | 1997-09-02 | ||
| JP27777197 | 1997-10-09 | ||
| JP9-277771 | 1997-10-09 | ||
| JP10-165725 | 1998-06-12 | ||
| JP16572598 | 1998-06-12 | ||
| PCT/JP1998/003915 WO1999011647A1 (en) | 1997-09-02 | 1998-08-31 | Fused thiophene compounds and medicinal use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000289527A Division JP4354106B2 (ja) | 1997-09-02 | 2000-09-22 | 縮合チオフェン化合物およびその医薬用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO1999011647A1 JPWO1999011647A1 (ja) | 2000-10-17 |
| JP3156933B2 true JP3156933B2 (ja) | 2001-04-16 |
Family
ID=27322564
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51595799A Expired - Fee Related JP3156933B2 (ja) | 1997-09-02 | 1998-08-31 | 縮合チオフェン化合物およびその医薬用途 |
| JP2000289527A Expired - Fee Related JP4354106B2 (ja) | 1997-09-02 | 2000-09-22 | 縮合チオフェン化合物およびその医薬用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000289527A Expired - Fee Related JP4354106B2 (ja) | 1997-09-02 | 2000-09-22 | 縮合チオフェン化合物およびその医薬用途 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6271225B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1016664B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP3156933B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20010021989A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1268949A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE244245T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU739385B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR9814042A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2302409A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69816102D1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0003718A3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL134812A0 (cg-RX-API-DMAC7.html) |
| NO (1) | NO20001049L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ503484A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2197491C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999011647A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6590083B1 (en) | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| US6399582B1 (en) | 1999-04-16 | 2002-06-04 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| US6751036B2 (en) * | 2000-08-04 | 2004-06-15 | Seagate Technology Llc | Tuning track density for data storage device |
| US8329924B2 (en) * | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
| EP2363396A1 (en) * | 2001-06-11 | 2011-09-07 | Virochem Pharma Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| ES2285227T3 (es) | 2002-08-05 | 2007-11-16 | Eli Lilly And Company | Arilbenzodiazepinas sustituidas con piperazina. |
| DE60332482D1 (de) | 2002-12-10 | 2010-06-17 | Virochem Pharma Inc | Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen |
| US20040236181A1 (en) * | 2003-04-01 | 2004-11-25 | Olympus Corporation | In-body information acquiring apparatus and power-supply circuit |
| CA2536107A1 (en) * | 2003-09-09 | 2005-03-24 | Eli Lilly And Company | Substituted piperazines of azepines, oxazepines, and thiazepines |
| RU2248205C1 (ru) * | 2003-09-18 | 2005-03-20 | Открытое акционерное общество "Щелковский витаминный завод" | Лекарственное средство в виде желатиновой капсулы |
| EP1713486A4 (en) * | 2003-12-02 | 2009-04-29 | Sheldon Leslie James | COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY |
| WO2005063771A1 (en) * | 2003-12-22 | 2005-07-14 | Teva Pharmaceutical Industries Ltd | Methods of preparing olanzapine |
| US7807828B2 (en) * | 2005-08-11 | 2010-10-05 | Hypnion, Inc. | Olanzapine analogs and methods of use thereof |
| SG176488A1 (en) * | 2006-11-15 | 2011-12-29 | Virochem Pharma Inc | Thiophene analogues for the treatment or prevention of flavivirus infections |
| PL395468A1 (pl) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego |
| JP6551671B2 (ja) * | 2015-08-11 | 2019-07-31 | 国立大学法人 熊本大学 | アルツハイマー治療薬 |
| US12365696B2 (en) | 2019-05-10 | 2025-07-22 | Dana-Farber Cancer Institute, Inc. | Small-molecule focal adhesion kinase (FAK) inhibitors |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995017400A1 (en) | 1993-12-23 | 1995-06-29 | Allelix Biopharmaceuticals Inc. | N-heterobicyclyl-piperazinyl or-piperadinyl tricyclic derivatives useful as dopamine receptor ligands |
| WO1996018621A1 (en) | 1994-12-12 | 1996-06-20 | Allelix Biopharmaceuticals Inc. | Alkyl-substituted compounds having dopamine receptor affinity |
| WO1996018623A1 (en) | 1994-12-12 | 1996-06-20 | Allelix Biopharmaceuticals Inc. | Benzyl-substituted compounds having dopamine receptor affinity |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL140242B (nl) | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
| CH468400A (de) | 1965-12-23 | 1969-02-15 | Sandoz Ag | Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen |
| US3683084A (en) | 1969-02-06 | 1972-08-08 | Jean Schmutz | Basically substituted heterocycles as anti-emetics |
| US3726977A (en) | 1969-02-06 | 1973-04-10 | Sandoz Ag | 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION |
| US3962248A (en) * | 1972-04-04 | 1976-06-08 | Sandoz, Inc. | Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines |
| SU629879A3 (ru) * | 1974-11-26 | 1978-10-25 | Лилли Индастриз Лимитед, (Фирма) | Способ получени тиено(1,5) бензодиазепинов или их солей |
| US4115568A (en) | 1974-11-26 | 1978-09-19 | Lilly Industries Limited | Thieno[3,2-b]-[1,5]benzodiazepines |
| US4172831A (en) | 1974-11-26 | 1979-10-30 | Lilly Industries Limited | Thieno-benzodiazepines |
| GB1533236A (en) * | 1975-11-24 | 1978-11-22 | Lilly Industries Ltd | Thieno(1,5)benzodiazepine intermediates |
| US4157444A (en) | 1978-03-13 | 1979-06-05 | American Cyanamid Company | 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines |
| GB9009229D0 (en) | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5700445A (en) | 1994-12-12 | 1997-12-23 | Allelix Biopharmaceuticals, Inc. | N-methyl piperazine compounds having dopamine receptor affinity |
| US5602124A (en) | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | 5-HT2 receptor ligands |
| US5576314A (en) | 1994-12-12 | 1996-11-19 | Allelix Biopharmaceuticals Inc. | Bicyclic nonane and decane compounds having dopamine receptor affinity |
| US5561127A (en) | 1994-12-19 | 1996-10-01 | Allelix Biopharmaceuticals, Inc. | Muscarinic receptor ligands |
-
1998
- 1998-08-31 AU AU88890/98A patent/AU739385B2/en not_active Ceased
- 1998-08-31 RU RU2000108433/04A patent/RU2197491C2/ru not_active IP Right Cessation
- 1998-08-31 WO PCT/JP1998/003915 patent/WO1999011647A1/ja not_active Ceased
- 1998-08-31 JP JP51595799A patent/JP3156933B2/ja not_active Expired - Fee Related
- 1998-08-31 DE DE69816102T patent/DE69816102D1/de not_active Expired - Lifetime
- 1998-08-31 CN CN98808681A patent/CN1268949A/zh active Pending
- 1998-08-31 IL IL13481298A patent/IL134812A0/xx unknown
- 1998-08-31 CA CA002302409A patent/CA2302409A1/en not_active Abandoned
- 1998-08-31 US US09/341,317 patent/US6271225B1/en not_active Expired - Lifetime
- 1998-08-31 AT AT98940666T patent/ATE244245T1/de not_active IP Right Cessation
- 1998-08-31 HU HU0003718A patent/HUP0003718A3/hu unknown
- 1998-08-31 KR KR1020007000556A patent/KR20010021989A/ko not_active Withdrawn
- 1998-08-31 NZ NZ503484A patent/NZ503484A/en unknown
- 1998-08-31 EP EP98940666A patent/EP1016664B1/en not_active Expired - Lifetime
-
1999
- 1999-07-08 BR BR9814042-6A patent/BR9814042A/pt not_active IP Right Cessation
-
2000
- 2000-03-01 NO NO20001049A patent/NO20001049L/no unknown
- 2000-09-22 JP JP2000289527A patent/JP4354106B2/ja not_active Expired - Fee Related
-
2001
- 2001-04-19 US US09/837,424 patent/US6455521B1/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995017400A1 (en) | 1993-12-23 | 1995-06-29 | Allelix Biopharmaceuticals Inc. | N-heterobicyclyl-piperazinyl or-piperadinyl tricyclic derivatives useful as dopamine receptor ligands |
| WO1996018621A1 (en) | 1994-12-12 | 1996-06-20 | Allelix Biopharmaceuticals Inc. | Alkyl-substituted compounds having dopamine receptor affinity |
| WO1996018623A1 (en) | 1994-12-12 | 1996-06-20 | Allelix Biopharmaceuticals Inc. | Benzyl-substituted compounds having dopamine receptor affinity |
Non-Patent Citations (1)
| Title |
|---|
| J.Med.Chem.,Vol.25,No.10(1982)P.1133−1140 |
Also Published As
| Publication number | Publication date |
|---|---|
| US6271225B1 (en) | 2001-08-07 |
| DE69816102D1 (de) | 2003-08-07 |
| NZ503484A (en) | 2001-10-26 |
| ATE244245T1 (de) | 2003-07-15 |
| IL134812A0 (en) | 2001-04-30 |
| NO20001049L (no) | 2000-04-03 |
| HUP0003718A3 (en) | 2002-11-28 |
| NO20001049D0 (no) | 2000-03-01 |
| KR20010021989A (ko) | 2001-03-15 |
| EP1016664A1 (en) | 2000-07-05 |
| HUP0003718A2 (hu) | 2001-09-28 |
| AU739385B2 (en) | 2001-10-11 |
| US20020042411A1 (en) | 2002-04-11 |
| EP1016664B1 (en) | 2003-07-02 |
| CN1268949A (zh) | 2000-10-04 |
| CA2302409A1 (en) | 1999-03-11 |
| WO1999011647A1 (en) | 1999-03-11 |
| RU2197491C2 (ru) | 2003-01-27 |
| JP2001072684A (ja) | 2001-03-21 |
| AU8889098A (en) | 1999-03-22 |
| US6455521B1 (en) | 2002-09-24 |
| EP1016664A4 (en) | 2001-01-24 |
| BR9814042A (pt) | 2000-10-03 |
| JP4354106B2 (ja) | 2009-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4354106B2 (ja) | 縮合チオフェン化合物およびその医薬用途 | |
| JP3239364B2 (ja) | 骨粗鬆症治療薬およびジアゼピン化合物 | |
| US4115574A (en) | Benzodiazepine derivatives | |
| KR102092147B1 (ko) | P2x4 수용체 길항제 | |
| JPWO1999011647A1 (ja) | 縮合チオフェン化合物およびその医薬用途 | |
| JP3130502B2 (ja) | 新規なキノリンスルフィド誘導体、その製造方法及び用途 | |
| JPH09291034A (ja) | 縮合ピリジン化合物およびその医薬としての用途 | |
| US20070010537A1 (en) | Fused pyramidine derivative and use thereof | |
| SK96494A3 (en) | Piperazine and piperidine derivatives, and their use as antipsychotic | |
| CN102245612A (zh) | 新型三环衍生物或其药物可接受的盐、其制备方法和含有它们的药物组合物 | |
| JPWO2009157196A1 (ja) | アミド化合物 | |
| CA2536313A1 (en) | Fused pyrimidine derivative and use thereof | |
| CN101679272B (zh) | 作为腺苷a3受体配体的三唑并[1,5-a]喹啉类 | |
| CA2565683C (en) | Substituted azepine derivatives as serotonin receptor modulators | |
| WO1997003986A1 (en) | Fused triazole compounds | |
| FI67550B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2,10-dihydro-4-piperazinyl-pyrazolo(3,4-b)(1,5)bensodiazepinderivat | |
| CS236753B2 (en) | Processing of thieno (1,5) benzodiazepine derivatives | |
| US4172831A (en) | Thieno-benzodiazepines | |
| JP2007505106A (ja) | アゼピン、オキサゼピン、およびチアゼピンの置換ピペラジン | |
| TWI495640B (zh) | 苯並氮呯化合物 | |
| KR20010022658A (ko) | 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도 | |
| NZ540768A (en) | Benzamide derivatives as oxytocin agonists and vasopressin antagonists | |
| JP2005097276A (ja) | 縮合ピリミジン誘導体およびその用途 | |
| JP5599802B2 (ja) | 縮合複素環誘導体およびその用途 | |
| HK1029340A (en) | Fused thiophene compounds and medicinal use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |